CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1

Oncogene

Volumn 36, Issue 18, 2017, Pages 2619-2627

  Zhu, W ^a,b   Gliddon, B L ^a   Jarman, K E ^a,b   Moretti, P A B ^a   Tin, T ^a   Parise, L V ^c   Woodcock, J M ^a   Powell, J A ^a,b   Ruszkiewicz, A ^a   Pitman, M R ^a   Pitson, S M ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM AND INTEGRIN BINDING PROTEIN 1; H RAS PROTEIN; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN; PROTEIN C FOS; RAS PROTEIN; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; CALCIUM; CALCIUM BINDING PROTEIN; CIB1 PROTEIN, HUMAN; HRAS PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; PHOSPHOTRANSFERASE; PROTEIN P21; SPHINGOSINE KINASE;

ACUTE MYELOID LEUKEMIA; ARTICLE; BINDING SITE; BONE MARROW BIOPSY; BREAST CARCINOMA; CANCER PROGNOSIS; CARCINOGENESIS; CELL MEMBRANE; COLONY FORMATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; ECTOPIC EXPRESSION; ENZYME ACTIVITY; ESTROGEN RECEPTOR NEGATIVE BREAST CANCER; FLUORESCENCE MICROSCOPY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; MULTIPLE CANCER; MYRISTYLATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR BIOPSY; UPREGULATION; WILD TYPE; BIOSYNTHESIS; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

CALCIUM; CALCIUM-BINDING PROTEINS; CARCINOGENESIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTO-ONCOGENE PROTEINS P21(RAS);

EID: 85004154221     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.428     Document Type: Article

References (48)

1. Naik UP, Patel PM, Parise LV. Identification of a novel calcium-binding protein that interacts with the integrin alphaIIb cytoplasmic domain. J Biol Chem 1997; 272: 4651-4654.
2. Yamniuk AP, Vogel HJ. Insights into the structure and function of calcium-A nd integrin-binding proteins. Calcium Binding Proteins 2006; 1: 150-155.
3. Naik MU, Nigam A, Manrai P, Millili P, Czymmek K, Sullivan M, et al. CIB1 deficiency results in impaired thrombosis: The potential role of CIB1 in outside-in signaling through integrin alpha IIb beta 3. J Thromb Haemost 2009; 7: 1906-1914.
4. Shock DD, Naik UP, Brittain JE, Alahari SK, Sondek J, Parise LV. Calciumdependent properties of CIB binding to the integrin alphaIIb cytoplasmic domain and translocation to the platelet cytoskeleton. Biochem J 1999; 342(Pt 3): 729-735.
5. Jarman KE, Moretti PA, Zebol JR, Pitson SM. Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium-A nd integrin-binding protein 1. J Biol Chem 2010; 285: 483-492.
6. Meyer T, York JD. Calcium-myristoyl switches turn on new lights. Nat Cell Biol 1999; 1: E93-E95.
7. Pitson SM, Xia P, Leclercq TM, Moretti PA, Zebol JR, Lynn HE, et al. Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med 2005; 201: 49-54.
8. Junrong T, Huancheng Z, Feng H, Yi G, Xiaoqin Y, Zhengmao L, et al. Proteomic identification of CIB1 as a potential diagnostic factor in hepatocellular carcinoma. J Biosci 2011; 36: 659-668.
9. Naik MU, Pham NT, Beebe K, Dai W, Naik UP. Calcium-dependent inhibition of polo-like kinase 3 activity by CIB1 in breast cancer cells. Int J Cancer 2011; 128: 587-596.
10. Nagayoshi Y, Nakamura M, Matsuoka K, Ohtsuka T, Mori Y, Kono H, et al. Profiling of autoantibodies in sera of pancreatic cancer patients. Ann Surg Oncol 2014; 21(Suppl 3): S459-S465.
11. Yuan W, Leisner TM, McFadden AW, Clark S, Hiller S, Maeda N, et al. CIB1 is essential for mouse spermatogenesis. Mol Cell Biol 2006; 26: 8507-8514.
12. Zayed MA, Yuan W, Chalothorn D, Faber JE, Parise LV. Tumor growth and angiogenesis is impaired in CIB1 knockout mice. J Angiogenes Res 2010; 2: 17.
13. Zayed MA, Yuan W, Leisner TM, Chalothorn D, McFadden AW, Schaller MD, et al. CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angiogenesis. Circ Res 2007; 101: 1185-1193.
14. Armacki M, Joodi G, Nimmagadda SC, de Kimpe L, Pusapati GV, Vandoninck S, et al. A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis. Oncogene 2013; 33: 1167-1180.
15. Leisner TM, Moran C, Holly SP, Parise LV. CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling. Oncogene 2013; 32: 4017-4027.
16. Black JL, Harrell JC, Leisner TM, Fellmeth MJ, George SD, Reinhold D, et al. CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer. Breast Cancer Res Treat 2015; 152: 337-346.
17. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6: 1-6.
18. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, et al. An online survival analysis tool to rapidly assess the effect of 22, 277 genes on breast cancer prognosis using microarray data of 1, 809 patients. Breast Cancer Res Treat 2010; 123: 725-731.
19. Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-smallcell lung cancer. PLoS One 2013; 8: E82241.
20. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012; 483: 570-575.
21. Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res 2012; 72: 2457-2467.
22. Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487: 330-337.
23. Al-Jehani RM, Jeyarajah AR, Hagen B, Hogdall EV, Oram DH, Jacobs IJ. Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis. J Natl Cancer Inst 1998; 90: 540-542.
24. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74.
25. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
26. Deng T, Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 1994; 371: 171-175.
27. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000; 14: 2501-2514.
28. Yoon KW, Cho JH, Lee JK, Kang YH, Chae JS, Kim YM, et al. CIB1 functions as a Ca(2 +)-sensitive modulator of stress-induced signaling by targeting ASK1. Proc Natl Acad Sci USA 2009; 106: 17389-17394.
29. Paugh SW, Paugh BS, Rahmani M, Kapitonov D, Almenara JA, Kordula T, et al. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 2008; 112: 1382-1391.
30. Gault CR, Eblen ST, Neumann CA, Hannun YA, Obeid LM. Oncogenic K-Ras regulates bioactive sphingolipids in a sphingosine kinase 1-dependent manner. J Biol Chem 2012; 287: 31794-31803.
31. Adams DR, Pyne S, Pyne NJ. Sphingosine kinases: Emerging structure-function insights. Trends Biochem Sci 2016; 41: 395-409.
32. Pitman MR, Powell JA, Coolen C, Moretti PA, Zebol JR, Pham DH, et al. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties. Oncotarget 2015; 6: 7065-7083.
33. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003; 63: 5962-5969.
34. Pitson SM, Moretti PA, Zebol JR, Xia P, Gamble JR, Vadas MA, et al. Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. J Biol Chem 2000; 275: 33945-33950.
35. Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW, et al. An oncogenic role of sphingosine kinase. Curr Biol 2000; 10: 1527-1530.
36. Naik MU, Naik UP. Contra-regulation of calcium-A nd integrin-binding protein 1-induced cell migration on fibronectin by PAK1 and MAP kinase signaling. J Cell Biochem 2011; 112: 3289-3299.
37. Pitson SM. Regulation of sphingosine kinase and sphingolipid signaling. Trends Biochem Sci 2011; 36: 97-107.
38. Pyne NJ, Pyne S. Sphingosine 1-phosphate and cancer. Nat Rev Cancer 2010; 10: 489-503.
39. Heffernan-Stroud LA, Obeid LM. Sphingosine kinase 1 in cancer. Adv Cancer Res 2013; 117: 201-235.
40. Pitson SM, Moretti PA, Zebol JR, Lynn HE, Xia P, Vadas MA, et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 2003; 22: 5491-5500.
41. Pitman MR, Barr RK, Gliddon BL, Magarey AM, Moretti PA, Pitson SM. A critical role for the protein phosphatase 2A B'alpha regulatory subunit in dephosphorylation of sphingosine kinase 1. Int J Biochem Cell Biol 2011; 43: 342-347.
42. Powell JA, Thomas D, Barry EF, Kok CH, McClure BJ, Tsykin A, et al. Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood 2009; 114: 4859-4870.
43. Di Fiore F, Blanchard F, Charbonnier F, Le Pessot F, Lamy A, Galais MP, et al. Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. Br J Cancer 2007; 96: 1166-1169.
44. Marte BM, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr Biol 1997; 7: 63-70.
45. Plowman SJ, Ariotti N, Goodall A, Parton RG, Hancock JF. Electrostatic interactions positively regulate K-Ras nanocluster formation and function. Mol Cell Biol 2008; 28: 4377-4385.
46. Pitman MR, Pham DH, Pitson SM. Isoform-selective assays for sphingosine kinase activity. Methods Mol Biol 2012; 874: 21-31.
47. Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G, et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 2004; 279: 52487-52492.
48. Ikawa M, Kominami K, Yoshimura Y, Tanaka K, Nishimune Y, Okabe M. A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP). FEBS Lett 1995; 375: 125-128.